|
Quality-of-Life Study of Patients With Previously Treated Ovarian Cancer Clinical Trials Information presented on Clinical Trials Search is not designed to be a substitute for certified medical advice, trips or professional assistance with a real medical doctor. We aren't docs. Always confer with your doctor about Quality-of-Life Study of Patients With Previously Treated Ovarian Cancer conditions. Clinical Trials Search.org is a website committed to listing clinical research studies in human subjects. Quality-of-Life Study of Patients With Previously Treated Ovarian Cancer Clinical research trials and Quality-of-Life Study of Patients With Previously Treated Ovarian Cancer health trials happen in many of cities across the US. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials generally measure the effectualness of new does drugs. The intention of the studies / projects is to figure out particular human healthcare questions. Clinical trials are a popular manner for doctors, government agencies, and private sector corporations to detect cures for all forms of circumstances, like Quality-of-Life Study of Patients With Previously Treated Ovarian Cancer. Quality-of-Life Study of Patients With Previously Treated Ovarian Cancer Clinical Trials and other clinical trials allow for volunteers to undergo medical treatment options before they are available to the general public. Most times the subjects get treatment for free of charge, and occasionally they are paid for their time. Occasionally there is a cost for a Quality-of-Life Study of Patients With Previously Treated Ovarian Cancer clinical trial. Subjects frequently get the best healthcare possible for their Quality-of-Life Study of Patients With Previously Treated Ovarian Cancer condition. Hazards are a reality, however, and could include more or frequent mD visits, health risks (possibly life-jeopardizing), and/or the treatment being ineffectual. Trials are federally regulated with exacting guidelines to protect clinical trials patients.
|
|
|
|
|
|
|
Home > "Q" Clinical Trials Conditions > Quality-of-Life Study of Patients With Previously Treated Ovarian Cancer  Quality-of-Life Study of Patients With Previously Treated Ovarian Cancer
Quality-of-Life Study of Patients With Previously Treated Ovarian Cancer
For Condition: stage 4 ovarian germ cell tumor,stage 1 ovarian germ cell tumor,recurrent ovarian germ cell tumor,stage 3 ovarian germ cell tumor,stage 2 ovarian germ cell tumor,Quality of Life
Status: No longer recruiting
Sponsor(s): National Cancer Institute (NCI) , Gynecologic Oncology Group
Synopsis: RATIONALE: Quality-of-life assessment of patients undergoing cancer treatment may help determine the intermediate- and long-term effects of treatment in patients with cancer. PURPOSE: Clinical trial to determine the quality of life of patients who have previously treated ovarian cancer.
Details: OBJECTIVES: I. Compare quality of life in terms of health status, sexual functioning, psychological/emotional well being, and social functioning in ovarian germ cell cancer survivors vs a matched healthy control group. II. Predict quality of life in these patients through the additive effects of cancer diagnosis and treatment, sociodemographic characteristics, other stressors, and social network variables. PROTOCOL OUTLINE: Patients identify up to 3 healthy acquaintance controls within 3 years of the same age. Patients and controls complete a written questionnaire, which takes about 30 minutes, and a telephone interview, which takes about 1 hour, to assess quality of life. PROJECTED ACCRUAL: A total of 190 patients and 190 healthy controls will be accrued for this study within 2 years.
Eligibility:
Study Type: Interventional, Educational/Counseling/Training
Minimum Age/Maximum Age: 18 Years/
Genders:
Protocol Entry Criteria: PROTOCOL ENTRY CRITERIA: --Disease Characteristics-- - History of early or advanced ovarian germ cell tumors - Continuously disease free for at least 2 years prior to study - Must have been enrolled on GOG protocols 45, 78, 90, and 116 or similar protocols of cisplatin-based chemotherapy at M.D. Anderson Cancer Center --Prior/Concurrent Therapy-- - Biologic therapy: Not specified - Chemotherapy: See Disease Characteristics - Endocrine therapy: Not specified - Radiotherapy: No prior radiotherapy - Surgery: Not specified --Patient Characteristics-- - Age: 18 and over - Performance status: Not specified - Life expectancy: Not specified - Hematopoietic: Not specified - Hepatic: Not specified - Renal: Not specified - Other: Must be able to complete a written questionnaire and telephone interview in English
Total Enrollment:
Location and Contact Information:
Overall Study Official:
StephenWilliams, Study Chair, Gynecologic Oncology Group
Indiana University Cancer Center
Indianapolis, Indiana, 46202-5289
United States
Chao Family Comprehensive Cancer Center
Orange, California, 92868
United States
University of Texas - MD Anderson Cancer Center
Houston, Texas, 77030-4009
United States
Evanston Northwestern Health Care
Evanston, Illinois, 60201
United States
Additional Information:
Study ID Numbers: CDR0000066937; GOG-9901
Study Start Date: April 1999
Record last reviewed: October 2003
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00003794
Other Quality Of Life Studies:
1. Antineoplaston Therapy in Treating Patients With Stage III or Stage IV Ovarian Cancer
2. Quality-of-Life Study of Patients With Previously Treated Ovarian Cancer
Related Studies:
Other Quality of Life Clinical Trials
Other Illinois Clinical Trials
Other Evanston Clinical Trials
Quality-of-Life Study of Patients With Previously Treated Ovarian Cancer
|
|
|
|
|
|
|
|
